Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Trending Topics

    business

    Budget Reactions: IIFL Cap neutral on Cadilla; little downside on Sun Pharma

    In an interview to CNBC-TV18, Bino Pathiparampil, vice president, IIFL Capital analyses the pharma sector wherein he reviews specific stocks like Sun Pharma and Cadila.

    first published: Mar 19, 2012 11:57 am

    LATEST VIDEOS

    Watch More →

    A collection of the most-viewed Moneycontrol videos.

    Watch and Follow our leading shows

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347